IL-6 FOR THERAPY OR PREVENTION OF CHEMOTHERAPY-INDUCED NEUROPATHY
    4.
    发明公开
    IL-6 FOR THERAPY OR PREVENTION OF CHEMOTHERAPY-INDUCED NEUROPATHY 审中-公开
    IL-6 ZUR BEHANDLUNG ODER PREVENTION VON DURCH CHEMOTHERAPIEAUSGELÖSTERNEUROPATHIE

    公开(公告)号:EP3124040A1

    公开(公告)日:2017-02-01

    申请号:EP16188978.7

    申请日:2005-04-28

    申请人: Merck Serono SA

    IPC分类号: A61K38/20 A61P25/02

    摘要: The present invention relates to the use of IL-6 in compositions and methods for therapy or prevention of chemotherapy-induced neuropathy (CIPN). More specifically, the invention relates to the use of a low dose of IL-6 for the treatment and/or prevention CIPN.

    摘要翻译: 本发明涉及IL-6在治疗或预防化疗诱导型神经病变(CIPN)的组合物和方法中的用途。 更具体地,本发明涉及低剂量IL-6用于治疗和/或预防CIPN的用途。

    CD16-II variants
    9.
    发明公开
    CD16-II variants 失效
    CD16-II变种

    公开(公告)号:EP1734119A3

    公开(公告)日:2012-12-05

    申请号:EP06008076.9

    申请日:1996-05-03

    申请人: Merck Serono SA

    发明人: Luo, Shun

    CPC分类号: C07K14/70535 A61K38/00

    摘要: Human CD16-II variants, DNA sequences coding for them, their use in therapy and/or in diagnosis of autoimmune diseases and inflammatory illnesses, as well as pharmaceutical compositions comprising them, are disclosed. The sequence listing for the new polypeptides is provided.